Llwytho...
P6
Tamoxifen, a selective estrogen receptor modulator, remains a standard of endocrine therapy for estrogen receptor alpha (ERα) positive breast cancer (Goldhirsch et al., 2013). Despite well-known advantages of tamoxifen treatment, approximately one third of patients experience a relapse or disease pr...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2015-11-01
|
| Cyfres: | EJC Supplements |
| Mynediad Ar-lein: | http://www.sciencedirect.com/science/article/pii/S1359634915000051 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|